Shape the future of cardiovascular care with predictive simulations

Powered by digital twin technology

Shape the future of cardiovascular care with predictive simulations

Powered by digital twin technology

We envision that the implementation of numerical simulation will enhance the safety and efficacy of minimally-invasive cardiovascular procedures, while simultaneously improving cost-effectiveness for the community.

patients
simulated

patents

clinical
centers

scientific
publications
sigle_CE_PSblue
marked*

PrediSurge develops a precision medicine platform for cardiovascular interventions. Based on pre-operative imaging, our technology enables the creation of patient-specific digital twins: numerical models simulating the biomechanical behavior of arteries and cardiac valves.

Our end goal is to make endovascular procedures ever safer, by providing physicians and Medtech companies with numerical tools to improve procedures planning and medical devices designs.

PlanOpᵀᴹ for MedTech

To de-risk early avant-garde technologies, compress design iteration period, time to market and to predict in-vivo performances.

PlanOpᵀᴹ for Clinicians

To investigate different approaches in device implantation and to determine the best strategy for a specific patient.

A collaborative HDS (Health Data Hosting) compliant platform to ease interactions between engineers and clinicians

  • Patient-specific digital twin
  • Intervention simulation
  • Quantitative analysis to compare strategies
  • Design adjustement for custom-made devices

Voice of Users

PSURGE_temoins_pr_millon
« Since we started to use this technology, we have been very impressed with the precision of fenestration positioning associated with outstanding intra and postoperative results […] »

Pr. A. Millon
Lyon University Hospitals
Lyon, France

PSURGE_temoins_pr_assadian

« “We strongly believe that this technique will be the gold standard for aortic stent-graft planning and other endovascular procedures in the very near future, bringing huge benefits to patients […] »

Pr. A. Assadian
Klinik Ottakring
Vienna, Austria

PSURGE_temoins_pr_millon
« […] PrediSurge technology will represent a significant breakthrough in planning and visualization for endovascular intervention. »

Pr. S. Haulon
Lannelongue Hospital
Paris, France

PSURGE_temoins_pr_messika
« PrediSurge technology will profoundly change the planning approach for mitral valve interventions. It will be used by most cardiac centers on a routine basis before any mitral intervention. »

Pr. D. Messika-Zeitoun
Professor of Cardiology
University of Ottawa Heart Institute

Into the NEWS

PrediSurge at « Les Pionniers » on BFM

PrediSurge at « Les Pionniers » on BFM

Last Friday, our CEO Bruno VIRIEUX's interview aired on BFM's renowned program, "Les Pionniers," hosted by the amazing Frédéric Mazzella. We are thrilled to have showcased Predisurge's cutting-edge digital twin and AI technology on such a prestigious platform." Hello,...

lire plus
HAPPY 7th ANNIVERSARY PrediSurge!

HAPPY 7th ANNIVERSARY PrediSurge!

March 3th marked a significant milestone as we celebrated the 7th anniversary of PrediSurge.     Over the past seven years, our commitment to pioneering research and pushing the boundaries of innovation in cardiovascular technology has been unwavering. Our...

lire plus
PrediSurge at CX Symposium 2024

PrediSurge at CX Symposium 2024

In April, PrediSurge took part in the Charing Cross 2024 Symposium in London. It has been a great opportunity to talk to doctors and industry, to show our advancements in cardiovascular technology and discuss potential collaborations. Here the main highlights of the...

lire plus

They trust us

PSURGE_slide_confiance_1
PSURGE_slide_confiance_2
PSURGE_slide_confiance_3
PSURGE_slide_confiance_3_MOB
PSURGE_slide_confiance_1_MOB
PSURGE_slide_confiance_2_MOB

Clinical centers

PSURGE_logo_stryker
PSURGE_logo_medtronic
PSURGE_logo_GE_healthcare
PSURGE_logo_terumo
PSURGE_logos_x4_industrials_MOB

Industrials

* This service is only available for designing custom-made stent-grafts in the European Union. This service is not a medical device under MDR.